3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Breast
1
Conditions
Prostatic Neoplasms
5
Ovarian Neoplasms
4
Breast Neoplasms
4
Pancreatic Neoplasms
3
Colorectal Neoplasms, Hereditary Nonpolyposis
3
Triple Negative Breast Neoplasms
2
Neoplastic Syndromes, Hereditary
2
Hereditary Breast and Ovarian Cancer Syndrome
2
Endometrial Neoplasms
2
Colorectal Neoplasms
2
Sarcoma
1
Rectal Neoplasms
1
Multiple Myeloma
1
Melanoma
1
Lymphoproliferative Disorders
1
Kidney Neoplasms
1
Hematologic Neoplasms
1
Fanconi Anemia, Complementation Group D1
1
Cytopenia
1
Congenital Bone Marrow Failure Syndromes
1
Colonic Neoplasms
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Intraductal, Noninfiltrating
1
Cancer Risk Syndrome
1
Breast Neoplasms, Male
1
Bone Marrow Failure Disorders
1
Advanced Malignant Neoplasm
1
Interventions
Ifosfamide
8
Doxorubicin
8
Blood Specimen Collection
8
Radiosurgery
7
Proton Therapy
5
Surveys and Questionnaires
4
Surgical Procedures, Operative
4
Standard of Care
4
Radiotherapy
4
Magnetic Resonance Spectroscopy
4
X-Rays
3
Vincristine
3
Radiation Dose Hypofractionation
3
Palliative Care
3
Methods
3
Mesna
3
pegfilgrastim
2
pazopanib
2
dexamethasone acetate
2
Trastuzumab
2
Transurethral Resection of Bladder
2
Restraint, Physical
2
Radiotherapy, Intensity-Modulated
2
Protons
2
Practice Guidelines as Topic
2
Neoadjuvant Therapy
2
Methotrexate
2
Melphalan
2
Heavy Ion Radiotherapy
2
Gene Expression Profiling
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Sarcoma
×
Genetic Counseling
×
Clear all
NCT05225428
2026-05-22
VERDI
Dana-Farber Cancer Institute
Phase NA
Recruiting
1,020 enrolled